Bioverativ Inc (BIVV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BIVV | EXEL | BMRN | ||
| Company | Bioverativ Inc | Exelixis Inc | Biomarin Pharmaceuticals | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 104.97 | 43.65 | 55.50 | ||
| High | 105.01 | 44.16 | 56.55 | ||
| Low | 104.97 | 43.54 | 55.44 | ||
| Latest | 104.98 | 43.98 | 56.21 | ||
| Change | +0.33 | +0.10 | +0.71 | ||
| % Change | +0.32% | +0.23% | +1.28% | ||
| Volume | 792,900 | 1,723,200 | 1,859,400 | ||
| 20-Day Average Volume | 2,587,600 | 2,496,870 | 2,004,810 | ||
| Previous Close | 104.65 | 43.88 | 55.50 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 104.18 | 42.05 | 56.61 | ||
| 20-Day Raw Stochastic | 98.80% | 94.41% | 33.14% | ||
| 20-Day Relative Strength | 86.97 | 56.62 | 46.55 | ||
| Weighted Alpha | +58.00 | +17.65 | -1.99 | ||
| Today's Opinion | N/A | 48% Buy | 8% Sell | ||
| Previous Opinion | N/A | 48% Buy | 24% Sell | ||
| Last Month's Opinion | N/A | 8% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.30% since 03/01/18 | +5.90% since 03/27/26 | +3.82% since 03/27/26 | ||
| Low | 104.14 on 03/06/18 | 41.57 on 03/30/26 | 53.94 on 03/30/26 | ||
| High | 105.01 on 03/08/18 | 44.19 on 04/01/26 | 57.50 on 04/01/26 | ||
| 1-Month | |||||
| %Chg | +1.78% since 02/08/18 | +5.86% since 03/06/26 | -8.03% since 03/06/26 | ||
| Low | 102.51 on 02/09/18 | 40.51 on 03/12/26 | 53.35 on 03/24/26 | ||
| High | 105.01 on 03/08/18 | 44.19 on 04/01/26 | 61.97 on 03/10/26 | ||
| 3-Month | |||||
| %Chg | +103.96% since 12/08/17 | +0.69% since 01/06/26 | -6.43% since 01/06/26 | ||
| Low | 51.25 on 12/11/17 | 39.71 on 03/02/26 | 53.35 on 03/24/26 | ||
| High | 105.01 on 03/08/18 | 46.31 on 01/07/26 | 66.28 on 02/24/26 | ||
| 6-Month | |||||
| %Chg | +83.92% since 09/08/17 | +9.92% since 10/06/25 | +1.08% since 10/06/25 | ||
| Low | 48.28 on 12/01/17 | 33.76 on 10/20/25 | 50.76 on 11/07/25 | ||
| High | 105.01 on 03/08/18 | 47.24 on 12/23/25 | 66.28 on 02/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,360,936 | 11,396,031 | 10,673,925 | ||
| Shares Outstanding, K | 108,220 | 259,709 | 192,323 | ||
| Annual Sales | 1,168,500,000 | 2,320,130,000 | 3,221,250,000 | ||
| Annual Net Income | 355,600,000 | 782,570,000 | 348,900,000 | ||
| Last Quarter Sales | 328,700,000 | 598,660,000 | 874,560,000 | ||
| Last Quarter Net Income | 96,300,000 | 244,530,000 | -46,570,000 | ||
| 60-Month Beta | N/A | 0.42 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.95 on 02/13/18 | 0.94 on 02/10/26 | 0.46 on 02/23/26 | ||
| Latest Earnings Date | 05/02/18 | 05/12/26 | 05/07/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 38.05 | 16.13 | 23.56 | ||